Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement
about
Menopause, hormone therapy and diabetes.Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients.Screening for Dysglycemia: Connecting Supply and Demand to Slow Growth in Diabetes Incidence.Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular DiseaseDiabetes screening intervals based on risk stratification.Predicting Risk of Type 2 Diabetes by Using Data on Easy-to-Measure Risk FactorsType 2 Diabetes: Why We Are Winning the Battle but Losing the War? 2015 Kelly West Award Lecture.Type 2 diabetes detection and management among insured adults.The State of Diabetes Prevention Policy in the USA Following the Affordable Care ActPatient Perceptions About Prediabetes and Preferences for Diabetes Prevention.Diabetes 2030: Insights from Yesterday, Today, and Future Trends.Incidence of diabetes after a partner's diagnosis.Use of Healthcare Services by Patients with Non-Communicable Diseases in Nepal: A Qualitative Study with Healthcare ProvidersDisparities in the Use of Diabetes Screening in Appalachia.An Interrupted Time Series Analysis to Determine the Effect of an Electronic Health Record-Based Intervention on Appropriate Screening for Type 2 Diabetes in Urban Primary Care Clinics in New York City.Outcomes of a Digital Health Program With Human Coaching for Diabetes Risk Reduction in a Medicare Population.Nutritional interventions for Alzheimer's prevention: a clinical precision medicine approach.Cardiometabolic Abnormalities Among Normal-Weight Persons From Five Racial/Ethnic Groups in the United States: A Cross-sectional Analysis of Two Cohort Studies.Performance of a Random Glucose Case-Finding Strategy to Detect Undiagnosed Diabetes.Cost-effectiveness of diabetes screening initiated through a dental visit.Comorbidity in multiple sclerosis: implications for patient care.Hemoglobin A1c levels and risk of sudden cardiac death: A nested case-control study.Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009.Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults.Survey of primary care providers' knowledge of screening for, diagnosing and managing prediabetes.A Missed Screening Opportunity for Diabetes.Fasting glucose levels, incident diabetes, subclinical atherosclerosis and cardiovascular events in apparently healthy adults: A 12-year longitudinal study.Screening for Prediabetes and Type 2 Diabetes Mellitus.Patient, Provider, and System Factors Associated With Failure to Follow-Up Elevated Glucose Results in Patients Without Diagnosed Diabetes.Systematic Diabetes Screening Using Point-of-Care HbA1c Testing Facilitates Identification of Prediabetes.Detection and Management of Diabetes in England: Results from the Health Survey for England.Updated clinical guidelines experience major reporting limitationsNational Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report.Determining the optimal screening interval for type 2 diabetes mellitus using a risk prediction model.Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans.Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry.Glucose challenge test screening for prediabetes and early diabetes.Preventing Diabetes in Primary Care: Providers' Perspectives About Diagnosing and Treating Prediabetes.Diabetes Risk Assessment in Latinas: Effectiveness of a Brief Diabetes Risk Questionnaire for Detecting Prediabetes in a Community-Based Sample.
P2860
Q30239769-FB355C2F-7DA0-46BF-9029-5D6F257840B5Q30392979-4C9B60B7-6634-4175-A2E2-6C55C8B77528Q36073711-F37F24BA-CEDB-4DD3-BAA3-E127BF559275Q36081910-5232EEFE-B871-42AB-AB25-C85B0B2F0292Q36153812-DA1BB983-504A-42D5-9AD4-7696A5CE8D9FQ36201511-744CC1C1-C6A5-4B84-9173-80A80BB418F4Q36302167-DFC53218-4161-4EE7-AEC8-5964CC5D39AAQ36820572-EFBF3822-D695-48C5-8068-F94AB5100B14Q37426318-E0F3EBD8-99BB-4D28-A218-F19E06C8D1E6Q37555692-289C9A64-FFC2-42C6-83EE-084F7F9B2C7CQ37582154-AFE9EA62-C3E4-45F3-9641-6C2306522B27Q37613117-49CAA34F-10FE-4462-99A8-B80A926FB48BQ38617077-2192D9DB-244B-4E8E-9D05-9EBA85F7DC74Q38648885-108EA405-145B-4C9D-8ECB-FBDEC92BD71FQ38689294-353681DD-ED71-42C6-A2A1-DAB0A3938426Q38723238-4AE5276C-3AF5-4748-9F98-6F9D34105DFBQ38758733-F06729C4-5154-465B-A959-DC9309BFAF57Q38818044-619E5C76-1C09-4B65-9FE5-9F979E64BE5AQ38849777-014ECF1F-BBD1-4AD6-A339-BE4DB9BC6FEDQ38916836-1D9A40B8-65D1-433D-9539-E5414F33A4A6Q38987368-58EAF20B-BE4C-4CAA-B530-623E68E9EC5BQ39183454-EF079E77-68BA-447D-AE5E-F092B25959B0Q39425445-038903BB-C6D5-4771-8CD1-463896CB15D4Q40074435-1A8EEFEE-8C15-42C6-B899-11A53128FC55Q40074446-8D6EBF96-12CF-4DF0-BD9F-3707EF401207Q40113745-1C9DA808-1C0C-4F64-A044-A88C974DE43EQ40397230-494FE691-4178-484F-B26C-DC6F8197109EQ40637380-9A2380BB-66CE-4032-8030-724CABD192D4Q41148378-48C2B63E-8ED1-4365-8FE9-8BE564CD4355Q41591552-C5A19B92-510A-409C-977D-9A382D28559CQ42316744-93A6E69A-4B22-4FCE-83DE-A046AB231F0DQ42371746-CAB1C0D3-296C-409E-85CA-6260219EAD40Q42376658-62ADBEA0-332E-443D-80C7-45B8CF5FAEB9Q46181268-A73FC08B-291F-4986-889E-880A4660F1EEQ46626562-72BA75DF-ADBB-4BAF-956B-6C174261AD7CQ47360675-85AB8AB5-EADC-4A77-8869-C3EE4DDA82ACQ47592068-7C183D5A-FC6D-4056-BB01-A5FE8BFE6607Q48037494-EEB9B947-8F4D-4E2A-BC1E-E8B935A14E8EQ49570483-E76F0E9F-EC5E-4EE9-9B13-554B0943738AQ49885396-D26489FC-54BD-4FFA-9B4B-FED0273CB643
P2860
Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Screening for Abnormal Blood G ...... Force Recommendation Statement
@ast
Screening for Abnormal Blood G ...... Force Recommendation Statement
@en
Screening for Abnormal Blood G ...... Force Recommendation Statement
@en-gb
Screening for Abnormal Blood G ...... Force Recommendation Statement
@nl
type
label
Screening for Abnormal Blood G ...... Force Recommendation Statement
@ast
Screening for Abnormal Blood G ...... Force Recommendation Statement
@en
Screening for Abnormal Blood G ...... Force Recommendation Statement
@en-gb
Screening for Abnormal Blood G ...... Force Recommendation Statement
@nl
prefLabel
Screening for Abnormal Blood G ...... Force Recommendation Statement
@ast
Screening for Abnormal Blood G ...... Force Recommendation Statement
@en
Screening for Abnormal Blood G ...... Force Recommendation Statement
@en-gb
Screening for Abnormal Blood G ...... Force Recommendation Statement
@nl
P3181
P356
P1476
Screening for Abnormal Blood G ...... Force Recommendation Statement
@en
P2093
Albert L. Siu
P3181
P356
10.7326/M15-2345
P407
P577
2015-10-27T00:00:00Z